Searched for
AFFORDABLE CANCER TREATMENT
Rs 1 lakh to Rs 30,000: Cancer immunotherapy gets cheaper, but will patients get the price benefit?Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...- Denzel Washington once sponsored a student’s Oxford education. Years later, he became Black Panther. Chadwick Boseman recalls his ‘you owe me money’ responseDenzel Washington once helped fund Chadwick Boseman’s summer drama programme at Oxford University, unaware the student would become Marvel’...
- New York City woman erased $119 million in medical debt for thousands of Americans. She died at 38, but turned grief of others into reliefCasey McIntyre, a New York City book publisher who died of stage four ovarian cancer at 38 in November 2023, left behind a final wish that ...
- The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
- Tata Trusts’ spending jumps 73% to Rs 1,556 crore in Noel Tata’s first full yearTata Trusts reported a 72.5% increase in philanthropic spending to Rs 1,556.31 crore in 2025-26. Major allocations included Rs 457.62 crore...
- Tata Trusts to build 40-50 not-for-profit hospitals, says chairman, as philanthropy shifts to proving impactChairman Noel Tata, in the Trusts' Annual Report for 2025-26, said that the group will also build lasting public institutions and be judged...
- Eyes now on Viksit, net zero later: Can India achieve high-income status by 2047 without compromising on climate promises?India aims to achieve a high-income economy status by 2047, requiring substantial economic growth and investment. However, ambitious climat...
- Protect patients and patents smartlyThe Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...
- Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
- Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Wall Street’s $10 billion India hospital bet sparks a fight over billsWall Street has poured about $10 billion into Indian hospital chains over the past five years, with investors including Blackstone, KKR, TP...
- Karnataka flags 52x mark-up on cancer drugs, seeks Centre's interventionKarnataka conducted inspections revealing significant price disparities between hospital procurement and patient billing for cancer drugs a...
- Kerala HC says exorbitant drug prices can trigger government intervention in patented medicinesThe Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...
- Mehli Mistry steps down as trustee of Tata Medical Centre Trust, declines re-electionMehli K Mistry has decided not to seek re-election as a trustee of the Tata Medical Centre Trust. His current term is set to end on Septemb...
- India needs five-year policy to make precision cancer care afforable, says expertIndia needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr ...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Before Ayushman Bharat, families sold their homes to afford treatment: J P NaddaUnion Health Minister J P Nadda said on Friday that the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana has transformed India's healthcare...
- Karnataka medical institute opened by PM plans free cancer immunotherapy for patientsThe Sri Madhusudan Sai Institute plans to offer free immunotherapy for cancer patients. A new 600-bed hospital will soon launch on campus, ...
Load More
